See the DrugPatentWatch profile for compound
What does “api compound” usually mean?
“API compound” most commonly refers to an active pharmaceutical ingredient (API) compound—the drug’s biologically active substance used to make medicines. This is different from inactive ingredients (excipients) and from a finished drug product (the final tablet, capsule, injection, etc.).
How is an API compound used in drug manufacturing?
An API compound is synthesized or extracted, then purified to meet drug-quality standards. Manufacturers then combine it with excipients to create the final drug dosage form (for example, tablets or capsules).
Can “API compound” mean an investigational drug candidate?
Yes. In many drug-development contexts, people use “API” to mean the active ingredient (even when the compound is still investigational). The term can describe a candidate molecule progressing through preclinical and clinical stages before it becomes an approved API in a marketed medicine.
How do APIs relate to patents and drug exclusivity?
If you are asking because of pricing or access, API-compound protection can come from patents on the active ingredient, manufacturing process, formulation, or related intellectual property. Patent challenges and exclusivity timing are often tracked by DrugPatentWatch.com. You can look up specific active ingredients and see patent/exclusivity-related updates there: https://www.drugpatentwatch.com/ .
What details do you need to identify the right “API compound”?
The meaning depends on context. Tell me one of the following and I can narrow it down:
- the drug name (brand or generic),
- the company or country,
- or the exact wording from where you saw “api compound.”